SIENA Score and CVP/PCWP Predict Mid-Term Prognosis After LVAD Implantation: A Single-Center Study
Journal of Cardiovascular Development and Disease · 16.06.2026 · 13 (6) · 273
DOI: 10.3390/jcdd13060273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 16.06.2026. Verfasst von Giulia Elena Mandoli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Policlinico "Le Scotte", 53100 Siena, Italy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
Left ventricular assist device (LVAD) implantation is a valuable alternative as a bridge to transplant but also as a destination therapy in ineligible patients. Right ventricular failure (RVF) is a major cause of short- and long-term mortality post-LVAD. We aimed to validate echocardiographic and hemodynamic parameters predictive of RVF and adverse outcomes post-LVAD; (2)
Methods
We screened a population of patients with end-stage heart failure selected for LVAD implantation according to SIENA protocol and standard international indications, including right heart catheterization (RHC). Individuals were followed up for 1 year with different time points for the development of RVF (primary endpoint) or mortality and hospitalization (secondary endpoint); (3)
Results
The population included 29 patients with a mean age of 63 ± 7 years with a mean ejection fraction of 23 ± 4%, mostly due to ischemic etiology. All the patients had a SIENA protocol score of 0–1 before LVAD, and none met the primary endpoint. Regarding the secondary endpoint, among all the tested clinical, laboratory, echo, and RHC indices, only a central venous pressure/wedge pressure (CVP/PCWP) ratio > 0.63 was significantly associated with adverse outcomes (ß = 2.99, p = 0.026); (4)
Conclusions
Excluding a pre-implantation RV dysfunction according to SIENA protocol significantly reduces the risk of post-LVAD RVF. The CVP/PCWP ratio may be an additional prognostic marker for mortality and rehospitalization in LVAD patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Policlinico "Le Scotte", 53100 Siena, Italy.
- Cardiac Surgery Unit, Cardio-Thoracic and Vascular Department, University of Siena, Policlinico "Le Scotte", 53100 Siena, Italy.
ORCID-Profile: Giulia Elena Mandoli, Maria Concetta Pastore, Nicolò Ghionzoli, Federico Landra, Marta Focardi, Enrico Emilio Diviggiano, Flavio D'Ascenzi, Luna Cavigli, Sonia Bernazzali, Matteo Cameli
Zitieren
APA
Mandoli, G. E., Barilli, M., Pastore, M. C., Foli, S., Ghionzoli, N., Landra, F., Focardi, M., Diviggiano, E. E., D'Ascenzi, F., Cavigli, L., Bernazzali, S., Maccherini, M., Valente, S., & Cameli, M. (2026). SIENA Score and CVP/PCWP Predict Mid-Term Prognosis After LVAD Implantation: A Single-Center Study. Journal of Cardiovascular Development and Disease, 13(6), 273. https://doi.org/10.3390/jcdd13060273
Vancouver
Mandoli GE, Barilli M, Pastore MC, Foli S, Ghionzoli N, Landra F, et al. SIENA Score and CVP/PCWP Predict Mid-Term Prognosis After LVAD Implantation: A Single-Center Study. Journal of Cardiovascular Development and Disease. 2026;13(6):273. doi:10.3390/jcdd13060273
BibTeX
@article{Mandoli2026,
author = {Mandoli, Giulia Elena and Barilli, Maria and Pastore, Maria Concetta and Foli, Silvia and Ghionzoli, Nicolò and Landra, Federico and Focardi, Marta and Diviggiano, Enrico Emilio and D'Ascenzi, Flavio and Cavigli, Luna and Bernazzali, Sonia and Maccherini, Massimo and Valente, Serafina and Cameli, Matteo},
title = {SIENA Score and CVP/PCWP Predict Mid-Term Prognosis After LVAD Implantation: A Single-Center Study},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {6},
pages = {273},
doi = {10.3390/jcdd13060273}
}
EUVIMED